A novel monocarboxylate transporter 8 gene mutation as a cause of severe neonatal hypotonia and developmental delay

Pediatrics. 2008 Jan;121(1):e199-202. doi: 10.1542/peds.2007-1247.

Abstract

Monocarboxylate transporter 8 acts as a specific cell membrane transporter for thyroxine and especially triiodothyronine into target cells. It is expressed in brain neurons and in many other tissues. The monocarboxylate transporter 8 gene resides on chromosome Xq13.2. An 11-month-old male infant was referred because of severe hypotonia from early life and global developmental delay. Thyroid-function tests showed normal thyrotropin levels and the characteristic for the disorder, including high serum triiodothyronine and low thyroxine concentrations. Molecular analysis of the monocarboxylate transporter 8 gene showed that the patient was hemizygous for a novel missense mutation P537L. This case highlights the importance of determining thyroid hormone levels, especially triiodothyronine, in infants with severe neonatal hypotonia.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Developmental Disabilities / diagnosis
  • Developmental Disabilities / genetics*
  • Follow-Up Studies
  • Gene Expression Regulation, Developmental
  • Genetic Predisposition to Disease
  • Humans
  • Infant
  • Male
  • Monocarboxylic Acid Transporters / genetics*
  • Muscle Hypotonia / diagnosis
  • Muscle Hypotonia / genetics
  • Mutation, Missense*
  • Myopathies, Structural, Congenital / diagnosis
  • Myopathies, Structural, Congenital / genetics*
  • Risk Assessment
  • Severity of Illness Index
  • Thyroid Function Tests

Substances

  • Monocarboxylic Acid Transporters